Click here for The Motley Fool’s resources on Coronavirus and the market.
The “ideal” level of delta-9 tetrahydrocannabinol (THC) in edible products has been found, if the results of a recently conducted study by OrganiGram Holdings (NASDAQ:OGI) are anything to go by.
The company conducted research on the attitudes of Canadian consumers toward marijuana edibles, delving into a variety of subjects around this topic. It surveyed 2,000 adults — both users and non-users cannabis — from whom it gleaned the following insights (among others):
- Collectively, people consider the ideal THC dosage to be 5 milligrams or less per serving.
- 3 in 10 respondents had consumed cannabis in the past year.
- The demographic with the highest usage rate was 19- to 34-year-olds.
- Of those interested in trying edibles, 61% would like to consume them in the form of baked goods. Among respondents aged 65 and older, that percentage rises to 66%.
- 68% of females interested in trying edibles are would prefer to try candy products. That figure is only 52% for males.
- 1 in 4 people who plan to consume edibles expect to do so in public spaces.
Image source: Getty Images
OrganiGram conducted its research late last year, around the time legalization in Canada entered the “Cannabis 2.0” phase. The public rollout of the cannabis-derivative products that became legal at that point has been slow and halting, however.
“These insights will not only help our product teams make informed decisions around product design but will help us understand what Canadians need to know most, the marijuana company said in a press release. “With this information, we can build thoughtful consumer resource materials around a number of crucial topics, including the importance of consistent dosage and transparency of composition of cannabis products to help consumers make empowered, informed purchase decisions”
OrganiGram’s shares rose by just over 5% Tuesday, essentially in sync with the broader market. The S&P 500 closed the day up just shy of 5%.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends OrganiGram Holdings. The Motley Fool has a disclosure policy.”>